欧洲放射肿瘤学市场预测至 2031 年 - 区域分析 - 按类型（外束放射治疗和内束放射治疗）和应用（乳腺癌、前列腺癌、肺癌、头颈癌、宫颈癌等）

Historic Data: 2021-2022   |   Base Year: 2023   |   Forecast Period: 2024-2031

Analysis - by Types (External Beam Radiation Therapy and Internal Beam Radiation Therapy) and Application (Breast Cancer, Prostate Cancer, Lung Cancer, Head & Neck Cancer, Cervical Cancer, and Others)

No. of Pages: 87    |    Report Code: BMIRE00030997    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Europe Radiation Oncology Market
Free Sample Buy Now
2023 年欧洲放射肿瘤学市场价值为 33.1721 亿美元，预计到 2031 年将达到 87.2307 亿美元；预计 2023 年至 2031 年的复合年增长率为 12.8%。

支持放射肿瘤学发展的举措推动欧洲放射肿瘤学市场

各国政府和组织正在推出利用放射疗法快速有效治疗癌症的任务和计划。2023 年 9 月，国际原子能机构 (IAEA) 宣布了“希望之光”旗舰癌症计划，旨在发展放射治疗基础设施。在美国、德国、英国、法国等发达国家，几乎所有患者都可以接受放射治疗。在中等收入国家，60% 的患者和低收入国家十分之一的患者可以接受放射治疗。 “希望之光癌症关爱全民”致力于在世界各地发展放射治疗服务。自该计划启动以来，各国已收到放射治疗设备和操作设备所需的培训，以便及时诊断和治疗。五大洲都参与了该计划，并为该计划贡献了 4550 万美元（4200 万欧元），私营部门投资了 768,902 美元（710,000 欧元）用于支持。此外，Elekta 等制造商与国际原子能机构签署了合作伙伴关系，通过向世界各地提供放射治疗设备来改善癌症治疗。此外，国际原子能机构开始培训来自不同领域的医疗保健专业人员，其中包括 14 名放射肿瘤学家、13 名医学物理学家、4 名核医学技术员、7 名核医学医生、7 名放射药剂师、16 名放射治疗技术员、7 名肿瘤科护士、4 名医学成像技术员和 7 名放射科医生。因此，预计放射治疗举措的激增将增加其在低收入国家的普及率，同时训练有素的专业人员和放射治疗基础设施的发展将在未来几年推动放射肿瘤学市场的增长。

欧洲放射肿瘤学市场概览

德国拥有先进的医疗保健基础设施，可以使用支持放射治疗程序实施的尖端技术。该国还以高度重视创新和研究而闻名。在德国运营的综合癌症中心提供多学科治疗计划，包括放射治疗、手术、化疗和其他医疗程序。2020 年，瓦里安宣布海德堡德国癌症研究中心 (DKFZ) 订购了自适应智能解决方案，这是该国首个 Ethos 疗法。这种由人工智能驱动的全方位解决方案旨在提高放射治疗的功效、适应性和能力。

欧洲放射肿瘤学市场收入及预测至 2031 年（百万美元）

欧洲放射肿瘤学市场细分

欧洲放射肿瘤学市场分为类型、应用和国家。

根据类型，欧洲放射肿瘤学市场分为外束放射治疗和内束放射治疗。外束放射治疗部分在 2023 年占据了更大的市场份额。

在应用方面，欧洲放射肿瘤学市场分为乳腺癌、前列腺癌、肺癌、头颈癌、宫颈癌等。乳腺癌部分在 2023 年占据了最大的市场份额。

按国家/地区，欧洲放射肿瘤学市场分为德国、英国、法国、西班牙、意大利和欧洲其他地区。 2023 年，德国占据了欧洲放射肿瘤学市场的主导份额。

Varian Medical Systems Inc、Elekta AB、Accuray Incorporated、IBA Worldwide (Ion Beam Applications SA)、Becton Dickinson and Co、Nordion、Mevion Medical Systems、NTP RADIOISOTOPES、Mallinckrodt Plc 和 Curium 是欧洲放射肿瘤学市场的一些领先公司。

Europe Radiation Oncology Strategic Insights

Strategic insights for Europe Radiation Oncology involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/europe-radiation-oncology-market-strategic-framework.webp
Get more information on this report

Europe Radiation Oncology Report Scope

Report Attribute Details
Market size in 2023 US$ 3,317.21 Million
Market Size by 2031 US$ 8,723.07 Million
Global CAGR (2023 - 2031) 12.8%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By 类型
  • 外照射放射治疗
  • 内照射放射治疗
By 应用
  • 乳腺癌
  • 前列腺癌
  • 肺癌
  • 头颈癌
  • 宫颈癌
Regions and Countries Covered 欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
Market leaders and key company profiles
  • Varian Medical Systems Inc.
  • Elekta AB.
  • Accuray Incorporated.
  • IBA Worldwide (Ion Beam Applications SA).
  • Becton Dickinson and Co.
  • Nordion.
  • Mevion Medical Systems.
  • NTP RADIOISOTOPES.
  • Mallinckrodt Plc.
  • Curium.
    		•
    Get more information on this report

    Europe Radiation Oncology Regional Insights

    The regional scope of Europe Radiation Oncology refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/europe-radiation-oncology-market-geography.webp
    Get more information on this report
    Identical Market Reports with other Region/Countries

    The List of Companies - Europe Radiation Oncology Market

    1. Varian Medical Systems Inc.
    2. Elekta AB.
    3. Accuray Incorporated.
    4. IBA Worldwide (Ion Beam Applications SA).
    5. Becton Dickinson and Co.
    6. Nordion.
    7. Mevion Medical Systems.
    8. NTP RADIOISOTOPES.
    9. Mallinckrodt Plc.
    10. Curium.
    Frequently Asked Questions
    How big is the Europe Radiation Oncology Market?

    The Europe Radiation Oncology Market is valued at US$ 3,317.21 Million in 2023, it is projected to reach US$ 8,723.07 Million by 2031.

    What is the CAGR for Europe Radiation Oncology Market by (2023 - 2031)?

    As per our report Europe Radiation Oncology Market, the market size is valued at US$ 3,317.21 Million in 2023, projecting it to reach US$ 8,723.07 Million by 2031. This translates to a CAGR of approximately 12.8% during the forecast period.

    What segments are covered in this report?

    The Europe Radiation Oncology Market report typically cover these key segments-

  • 类型 (外照射放射治疗, 内照射放射治疗)
  • 应用 (乳腺癌, 前列腺癌, 肺癌, 头颈癌, 宫颈癌)

    • What is the historic period, base year, and forecast period taken for Europe Radiation Oncology Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Radiation Oncology Market report:

  • Historic Period : 2021-2022
  • Base Year : 2023
  • Forecast Period : 2024-2031
    • Who are the major players in Europe Radiation Oncology Market?

    The Europe Radiation Oncology Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Varian Medical Systems Inc.
  • Elekta AB.
  • Accuray Incorporated.
  • IBA Worldwide (Ion Beam Applications SA).
  • Becton Dickinson and Co.
  • Nordion.
  • Mevion Medical Systems.
  • NTP RADIOISOTOPES.
  • Mallinckrodt Plc.
  • Curium.
    • Who should buy this report?

    The Europe Radiation Oncology Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Europe Radiation Oncology Market value chain can benefit from the information contained in a comprehensive market report.

    europe-radiation-oncology-market